Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024

The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024 report provides readers with the following key benefits:

In-depth understanding of preclinical stage deal trends since 2019
Access to headline, upfront, milestone and royalty data
Comprehensive access to over 1,800 preclinical stage deals together with contract documents if available
Detailed access to actual preclinical stage deals entered into by the leading big pharma and big biotech companies along with other biopharma companies
Analysis of the structure of preclinical stage agreements with numerous real life case studies
Identify leading preclinical stage deals by value since 2019
Identify the most active preclinical stage dealmakers since 2019
Full listing of preclinical stage deals by company A-Z, phase of development, deal type, therapy and technology focus
Understand the key deal terms companies have agreed in previous deals       
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Why do companies partner preclinical stage compounds?
2.1. Introduction
2.2. The role of preclinical stage partnering
2.2.1. In-licensing at preclinical stage
2.2.2. Out-licensing at preclinical stage
2.3. Difference between discovery, preclinical and clinical stage deals
2.4. Reasons for entering into preclinical stage partnering deals
2.4.1. Licensors reasons for entering preclinical stage deals
2.4.2. Licensees reasons for entering preclinical stage deals
2.5. The future of preclinical stage partnering deals

Chapter 3 – Preclinical stage deal strategies and structure
3.1. Introduction
3.2. At what stage do companies partner?
3.2.1. Partnering early in pharmaceutical / biotech
3.2.1.1. Discovery and preclinical stage partnering case studies
3.2.1.1.a. Case study 1
3.2.1.1.b. Case study 2
3.2.1.1.c. Case study 3
3.2.1.1.d. Case study 4
3.2.2. Partnering later in pharmaceutical/biotech
3.2.2.1. Clinical stage partnering case studies
3.2.2.1.a. Case study 5
3.2.2.1.b. Case study 6
3.2.2.1.c. Case study 7
3.2.2.1.d. Case study 8
3.3. Early and later stage partnering – a risk/cost comparison
3.4. What do companies spend on preclinical stage partnering?
3.5. Pure versus multi-component partnering deals
3.6. Pure licensing agreement structure
3.6.1. Example pure preclinical stage licensing agreements
3.6.1.a. Case study 9
3.6.1.b. Case study 10
3.7. Multicomponent preclinical stage partnering agreements
3.7.1. Example multicomponent preclinical stage clauses
3.7.1.a. Case study 11
3.7.1.b. Case study 12

Chapter 4 – Preclinical stage partnering payment strategies
4.1. Introduction
4.2. Preclinical stage payment strategies
4.3. Payment options
4.3.1. Headline values
4.3.2. Upfront payments
4.3.2.1. Conditionality of upfront payments
4.3.3. Loans
4.3.4. Convertible loans
4.3.5. Equity
4.3.6. R&D funding
4.3.7. Licensing fees
4.3.8. Milestone payments
4.3.9. Royalty payments
4.3.9.1. Issues affecting royalty rates
4.3.9.2. Royalties on combination products
4.3.9.2.a. Case study 13
4.3.9.3. Guaranteed minimum/maximum annual payments
4.3.9.4. Royalty stacking
4.3.9.5. Royalties and supply/purchase contracts
4.3.10. Quids
4.3.11. Option payments

Chapter 5 – Trends in preclinical stage deal making
5.1. Introduction
5.2. Preclinical stage partnering over the year
5.2.1. Attributes of preclinical deals
5.3. Preclinical stage partnering by deal type
5.4. Preclinical stage partnering by disease type
5.5. Partnering by preclinical stage technology type
5.6. Preclinical stage partnering by most active company, 2019 - 2024

Chapter 6 – Payment terms for preclinical stage partnering
6.1. Introduction
6.2. Guidelines for preclinical stage payment terms
6.2.1. Upfront payments
6.2.2. Milestone payments
6.2.3. Royalty payments
6.3. Preclinical stage payment terms – deal data analysis
6.3.1. Public data
6.3.2. Survey data
6.4. Payment terms analysis
6.4.1. Preclinical stage headline values
6.4.2. Preclinical stage deal upfront payments
6.4.3. Preclinical stage deal milestone payments
6.4.4. Preclinical stage royalty rates

Chapter 7 – Leading preclinical stage deals
7.1. Introduction
7.2. Top preclinical stage deals by value

Chapter 8 – Top 25 most active preclinical stage dealmakers
8.1. Introduction
8.2. Top 25 most active preclinical stage dealmakers

Chapter 9 – Preclinical stage partnering contracts directory
9.1. Introduction
9.2. Preclinical stage deals with contracts 2019 - 2024

Chapter 10 – Preclinical stage deal making by development stage
10.1. Introduction
10.2. Deals by preclinical stage

Appendices
Appendix 1 – Preclinical stage dealmaking by companies A-Z
Appendix 2 – Preclinical stage dealmaking by industry sector
Appendix 3 – Preclinical stage dealmaking by stage of development
Appendix 4 – Preclinical stage dealmaking by therapy area
Appendix 5 – Preclinical stage dealmaking by technology type

About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent titles from Current Partnering

Table of figures
Figure 1: Definition of discovery, preclinical and clinical phases in dealmaking
Figure 2: Components of the pure licensing deal structure
Figure 3: Payment options for preclinical stage partnering deals
Figure 4: Issues affecting royalty rates
Figure 5: Preclinical stage partnering frequency 2019 - 2024
Figure 6: Preclinical stage partnering by deal type since 2019
Figure 7: Preclinical stage partnering by disease type since 2019
Figure 8: Preclinical stage partnering by technology type since 2019
Figure 9: Top 25 most active preclinical stage dealmakers, 2019 - 2024
Figure 10: Review of upfront payments for preclinical stage deals
Figure 11: Review of milestone payments for preclinical stage deals
Figure 12: Review of royalty payments for preclinical stage deals
Figure 13: Preclinical stage deals with a headline value
Figure 14: Preclinical stage deals with an upfront value
Figure 15: Preclinical stage deals with a milestone value
Figure 16: Preclinical stage deals with a royalty rate value
Figure 17: Top preclinical stage deals by value since 2019
Figure 18: Most active preclinical stage dealmakers 2019 - 2024

Pricing options

• $3,995: single-user
• $5,995: 2-5 users
• $7,995: Corporate (unencrypted PDF)

A full explanation of license type definitions can be found here.

Our guarantee

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

Sales Support

If you have any questions about your report, we will do our best to resolve your query. Contact us direct.

Total Trust

Current Partnering is part of Biopharma Research Ltd., based in York, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2seventy bio, 3B Pharmaceuticals, 3D Medicines, 3rd People’s Hospital of Shenzhen, 4basebio Discovery, 4C Biomed, 4E Therapeutics, 4P-Pharma, 7 Hills Pharma, 9 Meters Biopharma, 23andMe, 180 Life Sciences, A*STAR Agency for Science, Technology and Research, A2 Biotherapeutics, Aadi Bioscience, Aarhus University, Aarvik Therapeutics, Abbisko Therapeutics, Abbvie, AbCellera Biologics, Abdul Latif Jameel Health, Abeona Therapeutics, Abera Bioscience, AbFero Pharmaceuticals, ABL Bio, Abound Bio, Abpro, AbSci, ABT Innovations, ABVC BioPharma, Abzena, Academy of Military Medical Sciences (China), ACADIA Pharmaceuticals, Accure Therapeutics, ACEA Therapeutics, Acepodia, Aceragen, Acer Therapeutics, Ache, Achieve Life Science, Aclipse Therapeutics, Actelion, Actimed Therapeutics, Actinium Pharmaceuticals, Acuitas Therapeutics, AcuraStem, Adalvo, Adaptimmune, AdaptVac, Adcendo, ADC Therapeutics, Addex Therapeutics, Adge Pharmaceuticals, Adhera Therapeutics, Adimab, Adjuvance Technologies, Adlai Nortye, Adolore Biotherapeutics, Advaccine Biotechnology, Advanced Biological Laboratories, Advanced Regenerative Manufacturing Institute, Aelis Pharma, Aethon Therapeutics, Aevi Genomic Medicine, AffaMed Therapeutics, Affimed Therapeutics, AGC Biologics, Ageless Biotech, Agenus Bio, AgeX Therapeutics, AgomAb Therapeutics, AgonOx, AiCuris, AIkido Pharma, AimedBio, AIM ImmunoTech, Aimmune Therapeutics, Aion Therapeutic, Airway Therapeutics, Akari Therapeutics, Akero Therapeutics, Akouos, AKSO Biopharmaceutical, Akston Biosciences, Albany Molecular Research, Alberta Cell Therapy Manufacturing, Alchemab, Aldevron, Alector, Alectos Therapeutics, Aleta Biotherapeutics, Alexion Pharmaceuticals, Algae-C, Algenex, Algernon Pharmaceuticals, Aligos Therapeutics, Alivexis, Alivio Therapeutics, Alkermes, Allarity Therapeutics, Alliance for Cancer Gene Therapy, Alligator Bioscience, Allist Pharma, Allogene Overland Biopharm, Allogene Therapeutics, Allorion Therapeutics, AllStripes, Almirall, Alnylam Pharmaceuticals, Alopexx, Alpha Cognition, Alphamab Biopharmaceuticals, Alpha Tau Medical, Alpine Immune Sciences, ALS Association, Altasciences, Altesa Biosciences, Altimmune, Alto Neuroscience, ALTuCELL, Alvotech, Alzheimer's Association, Ambiopharm, Ambrx, American National Multiple Sclerosis Society, Amerimmune, Amgen, Amicus Therapeutics, AmideBio, Amneal Pharmaceuticals, Amolyt Pharma, Ampio Pharmaceuticals, Amunix, Amygdala Neurosciences, Amyris, AN2 Therapeutics, Anagram Therapeutics, AnaptysBio, Angany, AnHeart Therapeutics, Anima Biotech, Animal Life Sciences, Anixa Biosciences, Ankyra Therapeutics, Annovis Bio, Anokion, Anova Enterprises, ANP Technologies, Antengene, Anthos Therapeutics, Antidote Therapeutics, Apic Bio, Apmonia Therapeutics, Apollomics, Apollon Formularies, Appili Therapeutics, Applied Biology, Applied BioMath, Applied Biomedical Science Institute, Applied DNA Sciences, Applied Genetic Technologies, AprilBio, APRINOIA Therapeutics, Aptahem, Aptorum Group, Aqualung Therapeutics, Aquinnah Pharmaceuticals, Aragen Bioscience, Arbor Biosciences, Arbor Biotechnologies, ARC Therapeutics, Arctic Therapeutics, Arctic University of Norway, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Ardena, Arecor, Argenta, argenx, Aridis Pharmaceuticals, Arizona State University, Arkuda Therapeutics, Armatus Bio, AroCell, Aromics, Arovella Therapeutics, Arrevus, ArriVent Biopharma, Arrowhead Pharmaceuticals, ARScience Biotherapeutics, ARTBIO, Artelo Biosciences, ArtemiLife, Artes Biotechnology, Artios Pharma, Artiva Biotherapeutics, Artizan Biosciences, Arvinas, Asahi Kasei, Ascentage Pharma, Asep Medical, Asher Biotherapeutics, Ashvattha Therapeutics, Asklepios Biopharmaceutical, Astellas Institute for Regenerative Medicine, Astellas Pharma, Astellas Pharma US, Astellas Venture Management, AstraZeneca, Astria Therapeutics, Astrogen, Asylia Therapeutics, Asymchem Laboratories, Atara Biotherapeutics, Atbtherapeutics, Atelerix, Ateria Health, Athenex, Atonco, Atreca, Attralus, ATUM, aTyr Pharma, Audentes Therapeutics, Augmenta, AUM Biosciences, AUM Biotech, AUM LifeTech, Aurealis Therapeutics, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, AusHealth, Austrian Research Promotion Agency, Autifony Therapeutics, Autotelic BIO, Avacta, Avania, Avectas, AVEO Oncology, Avery Therapeutics, Avicanna, Avid Bioservices, AVM Biotechnology, Avrobio, Axelys, Axoltis Pharma, Axovant Gene Therapies, Aytu BioPharma, Bach Biosciences, Baergic Bio, Banner MD Anderson Cancer Center, Barer Institute, Barth Syndrome Foundation, Bascom Palmer Eye Institute, Basilea Pharmaceutica, Batavia Biosciences, Bateman Horne Center, Bayer, Baylor College of Medicine, BayMedica, Beam Therapeutics, Be Biopharma, BeiGene, Beijing InnoCare Pharma, Beijing Tianshi Tongda Pharmaceuticals Technology, Bellicum Pharmaceuticals, Beroni Group, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, Beyond Batten Disease Foundation, BGI, BGN Technologies, Bharat Biotech, Bial, Bicycle Therapeutics, Bill and Melinda Gates Foundation, Bio-Techne, BioAesthetics, BioAge Labs, BioAnalytical Systems, Bioarchitech, BioArctic AB, BioArdis, BioAtla, BioCardia, BioCentriq, Bioceros, BioCina, Biocon, BioCryst Pharmaceuticals, BioCure, Biocytogen, Biodesix, Biodextris, BioEleven, Biofabri, Biogen, Bioharmony Therapeutics, Biohaven Pharmaceuticals, BioInvent, BioKey, Biolojic Design, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, Biomedical Catalyst Fund (UK), BioMed X Innovation Center, Biomica, Biomunex Pharmaceuticals, Bionaut Labs, Biond Biologics, BiondVax, Bionomics, BioNova Pharmaceuticals, BioNTech, BiopharmX, Bioprojet, Bioscience Pharma Partners, Biose Industrie, Biosion, Biosplice, Biotheus, Biotools, BioVaxys, Bioventure MDC, BioVersys, BioVie, BIRAD Research and Development Company, Bird Foundation, BJ Bioscience, Blacksmith Medicines, Blackstone, Blackstone Medical, Blau Pharma, Bloom Science, Bluebird Bio, BlueJay Therapeutics, Blueprint Medicines, BlueRock Therapeutics, Blue Water Vaccines, BlueWillow Biologics, Boehringer Ingelheim, Bohai Biomedical, Bold Therapeutics, Bolt Biotherapeutics, Bone Therapeutics, Boryung Pharmaceutical, Boston Pharmaceuticals, Boston University, Bpifrance, Brenus Pharma, BriaCell Therapeutics, BrickBio, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, BridGene Biosciences, Brigham and Women's Hospital, BrighGene Biomedical, Bright Peak Therapeutics, Brii Biosciences, Bristol-Myers Squibb, Brown University, Bugworks, Butantan Institute, C-Bridge Capital, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Caeregen Therapeutics, Cajal Neuroscience, Calidi Biotherapeutics, Califia Pharma, California Institute for Biomedical Research, California Institute for Regenerative Medicine, Calithera Biosciences, Calvert Laboratories, Calypso Biotech, Camargo Pharmaceutical Services, Cambrian Biopharma, CANbridge Pharmaceuticals, Cancer Prevention and Research Institute of Texas, Cancer Research UK, CancerVax, Candel Therapeutics, Cannabics Pharmaceuticals, Cannex Scientific, Cannomed Medical Cannabis Industries, Cantargia, Cantex Pharmaceuticals, CARB-X, Cardiovascular Solutions of Central Mississippi, Carina Biotech, Caris Life Sciences, Carisma Therapeutics, Carna BioSciences, CaroGen, CARsgen, Cascade Chemistry, Case Western Reserve University, CASI Pharmaceuticals, Castle Creek Biosciences, Catabasis Pharmaceuticals, Catalent, Catalyst Biosciences, Catamaran Bio, Catholic University Leuven, CB Therapeutics, Cedars-Sinai Medical Center, Cedilla Therapeutics, Celator, Celest Therapeutics, Celgene, Cell and Gene Therapy Catapult, CellBion, Cellect Biotechnology, Cellevolve Bio, Cellipont Bioservices, Cell Medica, Cell Mogrify, Celloram, Cell Point, Celltrion, Cellumed, Cellusion, Celmatix, Celonic, Celularity, Celyad, Centers for Disease Control and Prevention, Centessa Pharmaceuticals, Centivax, Centre for Addiction and Mental Health, Centre for Human Drug Research, Centre for Probe Development and Commercialization, Century Therapeutics, Cerecor, CereHealth, Cerveau Technologies, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Laboratories, Checkpoint Therapeutics, Cheil Pharm, Chemomab Therapeutics, Chemveda Life Sciences, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital of Philadelphia, Chimeron Bio, Chinook Therapeutics, Chiome Bioscience, Choroideremia Research Foundation, ChromaDex, Chugai Pharmaceutical, Ciitizen, CimCure, Cimeio Therapeutics, Cincinnati Children’s Hospital Medical Center, Cirqle Biomedical, Citius Pharmaceuticals, City College of New York, City of Hope, Clarus Therapeutics, Clavius Pharmaceuticals, Clearmind Medicine, Cleave Therapeutics, Clene Nanomedicine, Cleveland Clinic, Click Therapeutics, Clinton Health Access Initiative, Clover Biopharmaceuticals, Clovis Oncology, CMAB Biopharma, CMT Research Foundation, CNS Pharmaceuticals, Coalition for Epidemic Preparedness Innovations, Coave Therapeutics, Cobra Biologics, Codagenix, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Coeptis Therapeutics, Cognition Therapeutics, CohBar, Coherus Biosciences, CoImmune, Colorado State University, Columbia University, Columbia University Medical Center, CombiGene, Complix, Compugen, Confo Therapeutics, ConserV Bioscience, ContraFect, Copernicus Therapeutics, Corbus Pharmaceuticals, Cord Blood Registry, COUR Pharmaceutical, Covar Pharmaceuticals, Coya Therapeutics, CreaGen Biosciences, Creative Biolabs, Crescendo Bioscience, Crestone Pharma, Creyon Bio, CRISPR Therapeutics, Crohn's and Colitis Foundation of America, Crown Bioscience, Crozet BioPharma, CRT Pioneer Fund, CryoPort, CSIRO, CSL, CSL Behring, CSPC Megalith Biopharmaceutical, CStone Pharmaceuticals, CTMC, Cue Biopharma, Cullinan MICA, Cullinan Oncology, Cumulus Oncology, Curacle, Curadev Pharma, Curative Biotechnology, Cure Network Dolby Acceleration Partners, CureVac, Curia, Curigin, Curis, CVC, Cyagen Biosciences, Cyan Bio, Cybin, Cybrexa Therapeutics, Cyclacel Pharmaceuticals, Cyclerion Therapeutics, Cyclica, Cynata Therapeutics, Cystic Fibrosis Foundation, Cytea Bio, Cytiva, CytoAgents, Cytocom, Cytokinetics, Cytovance Biologics, Cytovant Sciences, Cytovation, CYTOVIA Therapeutics, Cyxone, Daewoong Pharmaceutical, Daiichi Sankyo, Dalton Pharma Services, Dana-Farber Cancer Institute, Danish Cancer Society Research Center, Danuo Science Group, Dare Bioscience, Day One Biopharmaceuticals, Debiopharm, Decibel Therapeutics, Defence Therapeutics, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Delix Therapeutics, DelSiTech, DeMelle OncoPharma, Denali Therapeutics, Dendreon, Denovo Biopharma, Department of Defense, Department of Health and Human Services, Dermelix Biotherapeutics, Dermira, DeuteRx, Dewpoint Therapeutics, Diaccurate, Diakonos Oncology, Dialectic Therapeutics, Diamond Therapeutics, Dianomi Therapeutics, Dicerna Pharmaceuticals, Diffusion Pharmaceuticals, Digestome Therapeutics, DiNAQOR, DiNonA, DiosCURE Therapeutics, Disc Medicine, Diverchim, Diverse Biotech, Dizal Pharmaceutical, DNX Biopharmaceuticals, Dogma Therapeutics, Dong-A ST, DoubleRainbow Biosciences, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, DTx Pharma, DualityBio, Duke-NUS Graduate Medical School Singapore, Duke University, Duke University Medical Center, DxVx, Dyadic International, Dynavax Technologies, DynPort Vaccine Company, DZNE German Center for Neurodegenerative Diseases, Eagle Pharmaceuticals, EA Pharma, Ecole Polytechnique de Montreal, Edesa Biotech, Edison Oncology, Editas Medicine, Eikonizo Therapeutics, Eikonoklastes Therapeutics, Eikon Therapeutics, Eisai, Elanco, Elevar Therapeutics, ElevateBio, ELIAS Animal Health, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Ellipses Pharma, Elpida Therapeutics, Elpiscience, Elthera, Emergent BioSolutions, Emmaus Life Sciences, Emory University, Enable Injections, ENA Respiratory, Endeavor BioMedicines, Endevica Bio, Endotherm, Enesi Pharma, Enigma Biomedical, Enlivex, Ennaid Therapeutics, Enochian Biosciences, Enosi Therapeutics, Ensem Therapeutics, Ensho Therapeutics, Ensysce Biosciences, Entasis Therapeutics, Enterome Bioscience, Enterprise Therapeutics, Entheon Biomedical, Entos Pharmaceuticals, Entrada Therapeutics, Enveric Biosciences, Enzolytics, Enzychem Lifesciences, Enzyvant Science, EOC Pharma, EpicentRx, EpimAb Biotherapeutics, Epivax, EpiVax Therapeutics, Epsilogen, Epygen Biotech, EQRx, Equilibre BioPharmaceuticals, Equillium, Eracal Therapeutics, Erasca, Erasmus University Medical Center, Escient Pharmaceuticals, EspeRare Foundation, ES Therapeutics, Eterna Therapeutics, Ethris, Eucure Biopharma, EuMentis Therapeutics, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Eurostars, Eureka Therapeutics, Eurocine Vaccines, Eurofins Discovery, European Commission, European Innovation Council, European Investment Bank, European Union, Eutilogics, Evax, Evaxion Biotech, Evelo Biosciences, Everest Medicines, Eversana, Evgen Pharma, Evolve BioSystems, Evommune, Evotec, Ewha Womans University, Exavir Therapeutics, ExCellThera, Excelra, Exelixis, Exeltis, ExonanoRNA, Exopharm, Exothera, Experimental Drug Development Centre, Expesicor, ExpreS2ion Biotechnologies, Exuma Biotech, Eyam Vaccines and Immunotherapeutics, Eyenovia, F-Star Therapeutics, Facit, Fapon Biopharma, Farmacore Biotechnology, Faron Pharmaceuticals, Fatro, Federal Ministry of Education and Research (BMBF), Federal Ministry of Health (Germany), Felix Biotechnology, FerGene, Ferrer, Ferring Pharmaceuticals, Fibriant, Fibrocell Science, Fibrogen, FibroGenesis, FightMND, Find Therapeutics, First Wave Bio, FivepHusion, Five Prime Therapeutics, Flame Biosciences, Flightpath Biosciences, Florida International University, Flow Pharma, FluGen, Fondation Cancer, Foresite Capital, Forge Biologics, Forge Therapeutics, Forsyth Institute, Fortress Biotech, Forty Seven, Fosun Pharmaceutical, Foundation Fighting Blindness, Frazier Healthcare Ventures, French National Blood Service, FSD Pharma, Fujifilm, FUJIFILM Cellular Dynamics, Fujifilm Diosynth Biotechnologies, Fulgent Pharma, Full-Life Technologies, Fusion Pharmaceuticals, FutureGen Biopharm, G-Tech Bio, G1 Therapeutics, GACI Global, Gaia, Galapagos, Galmed Pharmaceuticals, Gamida Cell, Gannex Pharma, Gastro-Intestinal Research Foundation, GC, GC Cell, GC Pharma, GEMMA Biotherapeutics, GEn1E Lifesciences, GeneCraft, Genelux, Genentech, GeneQuantum Healthcare, GeneQuine Biotherapeutics, Generex Biotechnology, Genetic Immunity, GeneTx Biotherapeutics, Genevant Sciences, Genezen, Genfit, Genmab, Gennova Biopharmaceuticals, Genocea Biosciences, GenomeFrontier Therapeutics, Genomma Lab Internacional, Genoscience, Genosera, Genprex, GenScript Biotech, GenScript ProBio, George Mason University, Georgetown University, George Washington University, German Red Cross, Giiant Pharma, Gilead Sciences, Ginkgo BioWorks, Glaukos, Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Cancer Technology, Global Coalition for Adaptive Research, Glympse Bio, Glytherix, GNP Bioscience, Golden Mountain Partners, Goldfinch Bio, Government of Canada, Government of Netherlands, GPCR Therapeutics, Gracell Biotechnologies, Gradalis, Grail, Graphite Bio, Gravitas Therapeutics, Graviton Bioscience, Great Bay Bio, Green Cross LabCell, Greenlight Biosciences, Greenwich LifeSciences, Grey Wolf Therapeutics, Griffith University, Gritstone Bio, GSK, GT Biopharma, GTP Bioways, Guangzhou Boji Medical Biotechnological, GW Pharmaceuticals, Gyroscope Therapeutics, Hadassah Medical Center, HaemaLogiX, Halozyme Therapeutics, Hamlet Pharma, HanAll Pharmaceuticals, Hande Sciences, Hangzhou Zhongmei Huadong Pharmaceutical, Hansa Biopharma, HanX Biopharmaceuticals, Harbour Biomed, Harmony Biosciences, Harpoon Therapeutics, Harvard Medical School, Harvard University, Havn Life Sciences, HCW Biologics, HDT Bio, Healion Bio, Healis Therapeutics, Health Holland, Heartseed, Hebrew University of Jerusalem, Heidelberg Pharma, Hemera Biosciences, Hemogenyx, Henlius Biotech, Henry M. Jackson Foundation, Hepion Pharmaceuticals, Herantis, HiberCell, HiFiBio, HilleVax, Hillstream BioPharma, Histogen, Hisun BioRay, HitGen, HK inno.N, Hoffmann La Roche, Hope Medicine, Horama, Horizon Europe, Horizon Therapeutics, Hoth Therapeutics, Huadong Medicine, Hualan Genetic, Humanetics, Hummingbird Bioscience, Hutchmed, Huyabio International, HUYA Bioscience, Hybridize Therapeutics, Hyloris Pharmaceuticals, Hypersomnia Foundation, IACTA Pharmaceuticals, IAMA Therapeutics, Iaso Therapeutics, iBio, Icahn School of Medicine at Mount Sinai, IcanoMAB, Ichnos Sciences, Ichor Medical Systems, Iconic Therapeutics, Iconovo, IDEAYA Biosciences, Idorsia, IGAN Biosciences, IGM Biosciences, Igyxos, Iksuda Therapeutics, Iktos, Ildong Pharmaceutical, ImCheck Therapeutics, Imcyse, Imeka, IMIDomics, Immatics Biotechnologies, Immodulon Therapeutics, Immune Biosolutions, ImmuneOncia Therapeutics, Immune System Regulation, Immune Therapeutics, ImmuNext, Immunic, ImmunityBio, ImmunoFlex, ImmunoForge, ImmunoGen, Immunome, Immunomedics, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoScape, Immuron, Immutep, ImmVira, IMPACT Therapeutics, IMP Clinical Supply Services, Imperial College London, ImQuest BioSciences, Imugene, Imunon, In4Derm, Incannex Healthcare, Incyte, Indapta Therapeutics, Indiana University, Indian Institute of Science Education and Research, Indivior, Inexia, Infectious Disease Research Institute (IDRI), Infex Therapeutics, InflamaCORE, Inflection Biosciences, Inhalation Sciences, Inhalon Biopharma, Inhibikase Therapeutics, Inhibrx, Inimmune, Inmagene Biopharmaceuticals, InMed Pharmaceuticals, INmune Bio, Innovate UK, Innovation Norway, Innovation Pharmaceuticals, Innovent Biologics, Inotrem, Inovio Pharmaceuticals, Inozyme Pharma, Insilico Medicine, InSilicoTrials, InSphero, Institut Curie, Institute for Bioscience and Biotechnology Research, Institute for Life Changing Medicines, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for the Promotion of Innovation by Science and Technology in Flanders, Institute of Endocrinology, Metabolism, and Reproduction, Institut Gustave Roussy, Institut Pasteur, Intarcia Therapeutics, Intec Pharma, Integral Molecular, Integrated BioTherapeutics, Intellia Therapeutics, Interius BioTherapeutics, Intravacc, Intrommune Therapeutics, iNtRON Biotechnology, IntuitiveX, Inventiva, Inventprise, Invetx, invIOs, iOnctura, Ionetix, Ionis Pharmaceuticals, Iovance Biotherapeutics, IOVaxis Therapeutics, ipCapital Group, I Peace, Ipsen, IQVIA, Ironwood Pharmaceuticals, ISD Immunotech, Isofol Medical, Isoprene Pharmaceuticals, IsoTherapeutics, Israeli National Authority for Technological Innovation, Israel Institute for Biological Research, Istari Oncology, Italfarmaco, iTolerance, Iveric Bio, Ivy Brain Tumor Center, Ixaka, Ix Therapeutics, J-STAR Research, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Jasper Therapeutics, Javelin Biotech, Jazz Pharmaceuticals, JCR Pharmaceuticals, jCyte, Jefferson Healthcare, Jellagen, Jemincare, Jenga Biosciences, Jenner Institute, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Jiangsu NHWA Pharmaceutical, Jiangsu QYuns Therapeutics, J Ints Bio, Ji Xing Pharmaceuticals, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Jounce Therapeutics, Joyo Pharmatech, JSC Pharmadis, Jubilant Radiopharma, Jubilant Therapeutics, Juniper Biologics, Junshi Biosciences, Juntendo University, Juvena Therapeutics, Juvenile Diabetes Research Foundation, JW Therapeutics, Kadimastem, Kadmon Pharmaceuticals, KAHR Medical, Kainos Medicines, Kaken Pharmaceutical, KaliVir Immunotherapeutics, Kamada, Kanaph Therapeutics, KangWon University Institute of Medical Science, Kanyr Pharma, Karolinska Institute, Karolinska University Hospital, Karuna Therapeutics, Karyopharm Therapeutics, Kashiv BioSciences, Kate Therapeutics, Kazia Therapeutics, KBI BioPharma, KDAc Therapeutics, Keck School of Medicine of USC, Kedrion Biopharma, Keio Gijuku University, Kelai Pharmaceuticals, KemPharm, Kemwell BioPharma, Kennedy Institute of Rheumatology, Kentucky Organ Donor Affiliates, Kenya Medical Research Institute, Khon Kaen University, Kiadis Pharma, Kindred Bio, Kineta, Kings College London, Kinnate Biopharma, Kinnear Pharmaceuticals, Kinoxis Therapeutics, Kintara Therapeutics, Kintor, Kiora Pharmaceuticals, Kiq, Kiromic Biopharma, Kleo Pharmaceuticals, Knight Therapeutics, Knopp Biosciences, Kolon Life Science, Konkuk University, Kovina Therapeutics, Kriya Therapeutics, Kronos Bio, KSQ Therapeutics, Kubota Vision, Kuria Therapeutics, KWF, KYAN Therapeutics, Kyn Therapeutics, Kyorin Pharmaceutical, Kyttaro, Kyverna Therapeutics, LabCentral, Laboratoires Thea, Lactiga, Laekna, Lamassu Pharma, LamKap Bio Group, LaNova Medicines, Lantern Pharma, La Paz Hospital, Launch Therapeutics, Laurel Therapeutics, Lava Therapeutics, Lawrence Livermore National Laboratory, Leap Therapeutics, Lee's Pharmaceutical, Lee Moffitt Cancer Center, LegoChem Biosciences, Leiden University, Leidos, Lenire Biosciences, LEO Pharma, Leucid Bio, Leukemia & Lymphoma Society, Leukocare, LeukoCom, LEXEO Therapeutics, LGC, LG Life Sciences, LianBio, Liechti Lab, LifeMax Laboratories, Ligand Pharmaceuticals, Light Chain Bioscience, Lighthouse Pharmaceuticals, LimmaTech Biologics, Lineage Cell Therapeutics, LineaRx, LinKinVax, Linnaeus Therapeutics, LiteVax, Livzon Mabpharm, Lixte Biotechnology, Lobe Sciences, Lobesity Pharma, Locana, Locus Biosciences, Lodo Therapeutics, LogicBio Therapeutics, London School of Medicine and Dentistry, Lonza, Louisiana State University, LSU Health Sciences Center, Lucid Psycheceuticals, Luminary Therapeutics, Lundbeck, Lung Biotechnology, Lupagen, Lupin Limited, Lupus Therapeutics, Luxembourg National Research Fund, LyGenesis, Lynk Pharmaceuticals, Lysogene, Lysosomal Therapeutics, Lytica Therapeutics, Lytix Biopharma, Maastricht University, MabCare Therapeutics, MAB Discovery, MabVax Therapeutics, Mabwell Bioscience, Macrogenics, Macromoltek, Macrostruct Holding & Consulting, Magenta Therapeutics, MagicMed Industries, MAIA Biotechnology, Maine Medical Center, Mallinckrodt Pharmaceuticals, Mammoth Biosciences, Manhattan BioSolutions, Mannin Research, MannKind Biopharmaceuticals, MapKure, Mapp Biopharmaceutical, Marinomed Biotechnologie, Maruho, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Massachusetts Institute of Technology, Mateon Therapeutics, MatriSys Bioscience, MaveriX Oncology, Mawson Infrastructure, Max-Planck, Maxcyte, Mayo Clinic, Maze Therapeutics, MC2 Therapeutics, McGill University, McMaster University, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, MDA Venture Philanthropy, MDimune, Meabco, Mebias Discovery, Medicago, Medical College of Wisconsin, Medical Research Council, Medical University of Innsbruck, Medical University of South Carolina, Medical University of Vienna, Medicines Discovery Catapult, MediciNova, MediGene, Medigen Vaccine Biologics, MediLink Therapeutics, MedinCell, Medison Pharma, Medivir, MediWound, MedPharm, Medshine Discovery, Medytox, Meitheal Pharmaceuticals, Melior Pharmaceuticals, Melodia Therapeutics, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Merck and Co, Merck KGaA, Merdury Biopharmaceutical, Merrimack Pharmaceuticals, Mersana Therapeutics, Merus, Metaclipse Therapeutics, Metagenomi, MetasTx, ME Therapeutics, MetVital, Metys Pharmaceuticals, Michael J Fox Foundation, Michigan State University, Microbion, Microbiotix, MicroCures, MicroQuin, Millennium, MiMedx, MimiVax, Minaris Regenerative Medicine, MiNA Therapeutics, MindBio Therapeutics, Mind Medicine, Mindset Pharma, MindShift Compounds, Minoryx Therapeutics, Minotaur Therapeutics, miRagen Therapeutics, Miralogx, Mira Pharmaceuticals, Mirati Therapeutics, Mirum Pharmaceuticals, Mission Bio, Mitacs, Mitochon Pharmaceuticals, Mitokinin, MITRO Biotech, Mochida Pharmaceutical, Moderna, ModeX Therapeutics, Modus Therapeutics, Molecular Partners, Moleculin Biotech, Monopar Therapeutics, MorphoSys, Mosanna Therapeutics, Mount Sinai Health System, Mount Sinai Medical Center, mProbe Laboratories, MThera Pharma, Multiple Myeloma Research Foundation, Multitude Therapeutics, Murdoch Childrens Research Institute, Muscular Dystrophy Association, Mustang Bio, MyBiotics Pharma, Mycenax Biotech, Mylan Pharmaceuticals, MyMD Pharmaceuticals, Mymetics, MyoKardia, MYOS, Myosana Therapeutics, Myovant Sciences, Myricx Bio, Myrtelle, Naason Science, Nanobiotix, Nanoform, Nanomerics, NaNotics, NanoTx Therapeutics, NanoVation Therapeutics, NanoViricides, NantKwest, NASA, Nascent Biotech, National Cancer Center, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Centre for Research and Development, National Comprehensive Cancer Network (NCCN), National Eye Institute, National Heart, Lung and Blood Institute, National Institute for Environmental Health Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), National Institutes of Health, National Jewish Health, National Research Council Canada, National Research Council of Canada, National Resilience, National Science Foundation, National University of Ireland, Galway (NUI Galway), Nationwide Children’s Hospital, Natural Sciences and  Engineering Research Council of Canada, Naval Medical Research Center, Navidea Biopharmaceuticals, Navigo Proteins, Navrogen, NAYA Biosciences, NBE Therapeutics, Nektar Therapeutics, Neo Gene Pharm, Neogene Therapeutics, NeoImmuneTech, Neotope, NephroDI Therapeutics, NervGen Pharma, Nerviano Medical Sciences, Nestle Health Science, NeuCen BioMed, NeuCyte, NeuExcell, Neumora Therapeutics, NeurAegis, Neuraly, Neuraxpharm, Neurgain Technologies, Neurix, NeurMedix, Neuro3 Therapeutics, NeuroBo Pharmaceuticals, Neurochase, Neurocrine Biosciences, NeuroCycle Therapeutics, Neurodon, Neurolixis, NeuroLucent, Neurophth Therapeutics, Neuropore Therapies, NeuroTrauma, NewCanna Hub, Newsoara Biopharma, New York Blood Center, New Zealand's Foundation for Research, Science and Technology, Nexel, Neximmune, NextCure, NEXT Oncology, NFL Biosciences, NiKang Therapeutics, NIMIUM Therapeutics, NIMML Institute, NImmune Biopharma, Ningbo NewBay Medical Technology, Ningbo Tai Kang Medical Technology, Nitrome Biosciences, NJCTTQ, Nkarta Therapeutics, NKGen Biotech, NKMax America, NLC Pharma, Noachis Terra, Nobelpharma, Noema Pharma, Noile-Immune Biotech, Nona Biosciences, North Carolina State University, Northeastern University, Northern Biologics, Northern Biomedical Research, NorthShore University HealthSystem, NorthStar Medical Radioisotopes, Northway Biotechpharma, NorthX Biologics, Nosopharm, Novan, NovaRock Biotherapeutics, Novartis, Novasep, Novavax, NoveCite, Novellus Therapeutics, Novelty Nobility, NovoCodex, Novo Nordisk, Novoron Bioscience, Novotech, NRG Therapeutics, NRx Pharmaceuticals, Nuance Pharma, Nucleai, Nucro Technics, Numab, NurrOn Pharmaceuticals, Nuvectis Pharma, Nykode Therapeutics, NysnoBio, NYU Langone Medical Center, Oak Hill Bio, OBI Pharma, Obsidian Therapeutics, Ocugen, Oculis, Oculogenex, Odimma Therapeutics, ODx, Odylia Therapeutics, Ohio State University, OKYO Pharma, Olatec Therapeutics, Oligomerix, OliX Pharmaceuticals, Ology Bioservices, Omeros, OmniaBio, OncoArendi Therapeutics, OncoC4, Oncoceutics, Oncoheroes Biosciences, Oncology Pharma, Oncology Venture, Oncolys BioPharma, Oncolytics Biotech, OncoSec Medical, Oncosyne, OncoVerity, OncoX BioPharma, Oncternal Therapeutics, OnCusp Therapeutics, OneThree Biotech, ONK Therapeutics, OnKure, Ono Pharmaceutical, Ontochem, Onward Therapeutics, Ophirex, Opsis Therapeutics, Opthea, Optimeos Life Sciences, Optimi Health, Opus Genetics, Oragenics, Oramed Pharmaceuticals, Oravax Medical, OrbiMed Asia Partners, Orexia Therapeutics, Organicell Regenerative Medicine, Organon, Orgenesis, ORIC Pharmaceuticals, Orion Biotechnology, Orphazyme, OrsoBio, Ortho Regenerative Technologies, Oryzon, OSE Immunotherapeutics, Osel, OSI Pharmaceuticals, Osivax, Ossianix, Ostentus Therapeutics, Otonomy, Otsuka, Ottawa Hospital Research Institute, Overland ADCT BioPharma, Overland Pharmaceuticals, Ovid Therapeutics, OWC Pharmaceutical Research, Owkin, Oxford BioMedica, Oxford BioTherapeutics, Oxford Vacmedix, OyaGen, Oyster Point Pharma, Ozette Technologies, Palisade Bio, Palleon Pharmaceuticals, Panacea Biotech, Panbela Therapeutics, Pancryos, Panolos Bioscience, Pantherics, Paracelsus Medical University, Paradigm Therapeutics, Paraza Pharma, Parent Project Muscular Dystrophy, Parkinsons Disease Foundation, Particle Sciences, Parvus Therapeutics, Pascal Biosciences, Passage Bio, Patagonia Pharmaceuticals, Path BioAnalytics, Pathogen and Microbiome Institute, PCI Biotech, PDS Biotechnology, PENAO, Pepper Bio, Peptide Logic, PeptiDream, Peptilogics, Peptron, Perelman School of Medicine, PersonGen BioTherapeutics, Perspective Therapeutics, Peter MacCallum Cancer Institute, Pfizer, PharmAbcine, PharmaEngine, PharmaEssentia, Pharmaleads, Pharmanovia, Pharmaron, PharmaTher, Pharmidex, Pharmsynthez, PhaseBio Pharmaceuticals, Pheno Therapeutics, Phico Therapeutics, Phio Pharmaceuticals, Phoenix PharmaLabs, PhoreMost, Phost’in Therapeutics, PhotonPharma, Pieris Pharmaceuticals, Pierre Fabre, PineTree Therapeutics, Pionyr Immunotherapeutics, Planet Biotechnology, Pleco Therapeutics, Plex Pharmaceuticals, Plexxikon, Pliant Therapeutics, Pluristyx, Plus Therapeutics, POINT Biopharma, Polyphor, Polyrizon, Portage Biotech, Poseida Therapeutics, PostEra, PPD, Praetego, Praxis Precision Medicines, Precision BioSciences, Precision Molecular, Precision NanoSystems, Pregene Biopharma, Premier Inc, Presage Biosciences, Primary Peptides, Primordial Genetics, Princeton University, Priovant Therapeutics, ProBioGen, Procarta Biosystems, Procyon Technologies, ProGen Co, Prokarium, Prometheus Biosciences, Proniras, Propella Therapeutics, Prophase Labs, Protalix BioTherapeutics, Prothelia, Prothena, ProtoKinetix, Psilera, PsyBio Therapeutics, PsychoGenics, Psylo, PTC Therapeutics, Public Health Vaccines, Pulmatrix, PulmoSIM Therapeutics, Pulthera, Puma Biotechnology, Purdue Pharma, Purdue University, Pure Biologics, Pure MHC, PureTech Health, Purisys, Purna Pharmaceuticals, Purnovate, Pyramid Biosciences, Pyxis Oncology, Q-Gen Cell Therapeutics, Q2 Solutions, Q32 Bio, Q BioMed, QED Therapeutics, Qilu Pharmaceutical, Qingdao Primedicine Pharmaceutical, Qpex Biopharma, Quadira Biosciences, Qualigen, Quebec Consortium for Drug Discovery, Quebec Government, Queen Mary University of London, Queensland Institute of Medical Research (QIMR), Queensland University of Technology, Quince Therapeutics, Quoin Pharmaceuticals, Quotient, QurAlis, Quratis, Qurient, R4D Biotech, Race Oncology, Radboud University Nijmegen, Radient Technologies, Rafael Pharmaceuticals, Rafarma Pharmaceuticals, Ragon Institute, Rain Oncology, Rakovina Therapeutics, Rakuten Medical, Rallybio, Rani Therapeutics, Ray Therapeutics, ReAlta Life Sciences, Recce Pharmaceuticals, Recipharm, Recro Pharma, Recurrent Respiratory Papillomatosis Foundation, Recursion, RedHill Biopharma, Redwood Bioscience, Redx Pharma, Refana, RefleXion Medical, Refuge Biotechnologies, Rega Institute for Medical Research, Regen BioPharma, Regenerative Care Network, Regenerative Medicine of Latin America, Regeneron Pharmaceuticals, Regenxbio, Regis Technologies, Reglagene, Regranion, Regulus Therapeutics, ReiThera, Releviate Therapeutics, Remedium Bio, Renalys Pharma, ReNeuron, Renew Biopharma, Renibus Therapeutics, Repare Therapeutics, ReproCell, Repurpose.AI, Rescue Hearing, Resilience, RespireRx Pharmaceuticals, resTORbio, Revelar Biotherapeutics, Revive Therapeutics, Revolution Medicines, Rexgenero, Reyon Pharmaceuticals, Rgene, RH Nanopharmacuticals, Ribon Therapeutics, Richard King Mellon Foundation, Ridgeback Biotherapeutics, Rigel Pharmaceuticals, Rigenerand, Riparian Pharmaceuticals, Riptide Bioscience, Roche, Rockefeller University, Rocket Pharmaceuticals, RocketVax, Roivant Sciences, RosVivo Therapeutics, Roswell Park Cancer Institute, RQ Biotechnology, RS BioTherapeutics, RTW Investments, Rubedo Life Sciences, Rubic One Health, RubrYc Therapeutics, Rugen Therapeutics, Rumi Scientific, Rumpus Therapeutics, Ryne Biotechnology, Ryvu Therapeutics, SAB Biotherapeutics, Sable Therapeutics, Sage Therapeutics, Saiba, Saint-Gobain Life Sciences, Sairopa, Salarius Pharmaceuticals, Salipro Biotech, Salix Pharmaceuticals, Salk Institute, Samsung Bioepis, Samsung Biologics, Samyang Biopharmaceuticals, Sana Biotechnology, SanegeneBio, Sanford Burnham Institute, Sangamo Therapeutics, San Gerardo Hospital, Sanofi, Sansero Life Sciences, Santen Pharmaceutical, Sant Joan de Déu-Barcelona Children’s Hospital, Sapien Biosciences, Sapience Therapeutics, Sapphire Biotech, Sapreme Technologies, Sarcomatrix Therapeutics, SarcoMed USA, Sarepta Therapeutics, Sartorius, SATT Conectus Alsace, SATT Nord, Savant HWP, Scandinavian Biopharma, Scandion Oncology, Scenic Biotech, Schrodinger, SciClone Pharmaceuticals, SciNeuro Pharmaceuticals, Scintomics, Scipher Medicine, SciSparc, Sciwind Biosciences, Scohia Pharma, Scopus BioPharma, Scorpion Therapeutics, Scottish Enterprise, Scripps Research Institute, Scynexis, Seagen, Seal Rock Therapeutics, Seattle Children's Hospital, Seattle Children's Therapeutics, Seattle Genetics, Second Genome, Seelos Therapeutics, Seismic Therapeutic, Selecta Biosciences, SelectImmune Pharma, Selecxine, Selenity Pharmaceuticals, Selexis, SELLAS Life Sciences Group, Sen-Jam Pharmaceutical, Senai Cimatec, Sensei Biotherapeutics, Sensorion, Senti Biosciences, Sentinel Oncology, SeraNovo, Seraph Research Institute, Serina Therapeutics, Sernova, Serum Institute of India, Seven and Eight Biopharmaceuticals, SFJ Pharmaceuticals, Shandong Fontacea Pharmaceutical, Shanghai Ark Biopharmaceutical, Shanghai Institute of Materia Medica, Shanghai Medicilon, Shanghai Pharmaceuticals Holdings, ShangPharma, Shaperon, Shenogen Pharma, Shenzhen Chipscreen Biosciences, Shionogi, Shionogi Pharma, Shoreline Biosciences, Shorla Pharma, Shuttle Pharmaceuticals, Sierra Oncology, SIGA Technologies, Sigilon Therapeutics, SignPath Pharmaceuticals, Silence Therapeutics, Silk Road Therapeutics, Silo Pharma, Simcere Pharmaceuticals, Simcha Therapeutics, Similis Bio, SimonMed Imaging, Sinclair Research, Sino Biopharmaceutical, Sinopia Biosciences, Sinorda Biomedicine, Sinotek-Advocates International Industry Development, Sinovac Biotech, Sirnaomics, SiSaf, SiteOne Therapeutics, SK Biopharmaceuticals, Skive Hospital, Skye Bioscience, Skymount Medical, Smart Immune, SN BioScience, Solarvest BioEnergy, Solid Biosciences, Soligenix, Solve GNE, SOM Biotech, Sonnet BioTherapeutics, Sorrento Therapeutics, Sosei, Sosei Heptares, SOTIO, Sourasky Medical Center, Southern Research Institute, Southwest College of Naturopathic Medicine & Health Sciences, Spanish National Research Council, Spark Therapeutics, SpectronRx, SpectrumX, Spero Therapeutics, Spherix, Spicona, Spinogenix, Spring Bank Pharmaceuticals, SpringWorks Therapeutics, SpyBiotech, St. Jude Children's Research Hospital, Stanford University, Statens Serum Institute, STCube, Stealth BioTherapeutics, Stella Diagnostics, StemCardia, Stemedica Cell Technologies, Stemline Therapeutics, Sterling Pharmaceutical Services, Stimunity, Stoke Therapeutics, Strand Therapeutics, Strategic Innovation Fund, Strykagen, Stuart Therapeutics, St Vincent’s Institute of Medical Research, Suanfarma, SUDA Pharmaceuticals, Sumitomo Dainippon Pharma, Sumitomo Pharmaceuticals, Sunesis Pharmaceuticals, Sunovion Pharmaceuticals, SunRock Biopharma, Sunshine Biopharma, Surface Oncology, Surrozen, Sutro Biopharma, SutroVax, Suzhou GenHouse, Suzhou Porton Advanced Solutions, Suzhou Runxin Biotechnology, Swift Biosciences, Swiss Federal Funding Programme, Sylics Contract Research, Symbiosis, Symvivo, SynAct Pharma, Synaffix, Syncromune, SynDevRx, Syngene, Syngene International, Synspira, Synthekine, Synthetic Biologics, Syracuse University, Systems Oncology, T-MAXIMUM Biotech, TaiGen Biotechnology, Taisho Pharmaceutical, Takara Bio, Takeda Pharmaceutical, Takis Biotech, Talaris Therapeutics, Talee Bio, Talix Therapeutics, Tallac Therapeutics, Tampere University Hospital, Tango Therapeutics, Tantu Therapeutics, Targeted Pharmaceutical, Targovax, Tarsius Pharma, Tarsus Pharmaceuticals, Tarveda Therapeutics, Tavotek Biotherapeutics, TAXIS Pharmaceuticals, Taysha Gene Therapies, TB Alliance, TeamedOn International, TechnoVax, Tel Aviv Sourasky Medical Center, Telix Pharmaceuticals, Telo Genomics, Telomir Pharmaceuticals, Tempest Therapeutics, Tempus, TeneoBio, TeneoOne, Terran Biosciences, Terumo Blood and Cell Technologies, Tessa Therapeutics, Tetra Bio-Pharma, Teva Pharmaceutical Industries, Tevogen Bio, Texas A&M University, Texas Biomedical Research Institute, Texas Lung Injury Institute, TFF Pharmaceuticals, TG Therapeutics, The International AIDS Vaccine Initiative, Themis Bioscience, Theragnostics, Therapeutics Incorporated, Therapeutic Solutions International, Therapix Bio, Therapyx, Theratechnologies, Theravance Biopharma, TheraVasc, The Regents of the University of California, Theriva Biologics, Thermo Fisher Scientific, Thirona Bio, ThirtyFiveBio, Thomas Jefferson University, Tianjin CanSino Biotechnology, Tiba Biotech, Tiburio Therapeutics, TILT Biotherapeutics, Tiziana Life Sciences, Tizona Therapeutics, Tmunity Therapeutics, TNAX Biopharma, Todos Medical, Tome Biosciences, TONIX Pharmaceuticals, Toregem BioPharma, Torii Pharmaceutical, Tornado Therapeutics, Tottori University, TRACON Pharmaceuticals, Transcend Therapeutics, Transgene, Transimmune, Transpire, TransThera, Travere Therapeutics, Traverse Biosciences, Treadwell Therapeutics, TreeFrog Therapeutics, Trefoil Therapeutics, Trellis Bioscience, Trestle Biotherapeutics, TrialSpark, Trigone Pharma, TriLink BioTechnologies, Trinity College Dublin, Triphase Accelerator, TriSalus Life Sciences, Triumvira Immunologics, TrovaGene, TScan Therapeutics, Tsinghua University, TTC, TTP Group, Tubulis, Tufts Medical Center, Tufts University, Tulane University, Turning Point Therapeutics, Turnstone Biologics, Turn Therapeutics, Tvardi Therapeutics, Twist Bioscience, TYG Oncology, UAB Research Foundation, Ubiquigent, Ubix Therapeutics, UCB, UK Government, Ultragenyx Pharmaceuticals, Umoja Biopharma, UniQure, United Therapeutics, UNITY Biotechnology, Univercells, University College London, University Gottingen, University Health Network, University Hospital Bonn, University of Adelaide, University of Alberta, University of Antwerp, University of Arizona, University of Bath, University of Bonn, University of British Columbia, University of Calgary, University of California, Davis, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California Los Angeles, University of California Riverside, University of California San Francisco, University of Campinas, University of Colorado, University of Connecticut, University of Copenhagen, University of Dundee, University of Edinburgh, University of Florida, University of Georgia, University of Guelph, University of Hong Kong, University of Kentucky, University of Lausanne, University of Leeds, University of Leipzig, University of Lethbridge, University of Leuven, University of Louisville, University of Maryland, University of Maryland Baltimore, University of Massachusetts, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Miami Miller School of Medicine, University of Michigan, University of Milano-Bicocca, University of Minnesota, University of Missouri, University of Montreal, University of Munster, University of Oklahoma, University of Ottawa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Quebec, University of Queensland, University of Rochester, University of Saskatchewan, University of Sheffield, University of Southampton, University of South Australia, University of South Florida, University of Surrey, University of Texas Health SCience Center at San Antonio, University of Texas Health Science Center at Tyler, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of Toronto, University of Twente, University of Virginia, University of Washington, University of Wisconsin, University of Wisconsin-Madison, University of Zaragoza, University of Zurich, Unum Therapeutics, UroGen Pharma, US Army Institute of Surgical Research (USAISR), US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Government, Usher III, Utrecht University, UT Southwestern Medical Center, UWM Research Foundation, Vaccibody, Vaccizone, Valbiotis, ValenzaBio, Valneva, Valo Therapeutics, Vanderbilt University, Varian Biopharmaceuticals, Variation Biotechnologies, VaxAlta, Vaxart, Vaxcyte, Vaxess Technologies, Vaxil BioTherapeutics, VaxNewMo, Vaxxas, VBL Therapeutics, Vectura, Vedanta Biosciences, Veloxis Pharmaceuticals, VenatoRx, Ventus Therapeutics, Veraxa Biotech, Verge Genomics, VerImmune, Verndari, Versatope Therapeutics, Verseau Therapeutics, Vertex Pharmaceuticals, Verve Therapeutics, ViaCyte, Viamet Pharmaceuticals, Vibalogics, Victoria University, Viela Bio, Viewpoint Molecular Targeting, Vigene Biosciences, ViGeneron, Vincera Pharma, Vinnova, ViralClear Pharmaceuticals, Viralgen, Vir Biotechnology, Virginia Catalyst, Virginia Commonwealth University, Virios Therapeutics, Viroclinics Biosciences, Virpax Pharmaceuticals, Visgenx, Vision Institute, Visirna Therapeutics, Visus Therapeutics, VitriVax, Viva Biotech, VivaCell Biotechnology Espana, Vivace Therapeutics, VIVEbiotech, Vivet Therapeutics, Vivoryon Therapeutics, Vivtex, Volastra Therapeutics, Voltron Therapeutics, Vor Biopharma, Voronoi, Voxtur, Voyager Therapeutics, VyGen-Bio, VYNE Therapeutics, Vyriad, Wageningen University, Washington University in St Louis, WaVe Lifesciences, WCTE, Weill Cornell Medical College, Wellcome Trust, Werewolf Therapeutics, Westport Bio, Wigen Biomedicine, William Harvey Research Instutute, Willow Biosciences, WindMIL Therapeutics, Windtree Therapeutics, Wistar Institute, W L Gore, Worldwide Clinical Trials, WPD Pharmaceuticals, WuXi Advanced Therapies, Wuxi Apptec Laboratory Services, WuXi Biologics, Wuxi Shuangliang Biotechnology, Wuxi STA, X-chem, Xbiome, Xencor, Xenon Pharmaceuticals, Xiamen Biotime Biotechnology, XNK Therapeutics, Xoma, Xortx Therapeutics, Xyphos Biosciences, Y-Biologics, Y-Trap, Yale Cancer Center, Yale University, Yeda Research and Development Company, Yisheng Biopharma, Yissum Research Development, Ymmunobio, YSP Industries, Yufan Biotechnologies, Yuhan Corporation, Yumanity Therapeutics, ZAI Laboratory, Zelira Therapeutics, Zenas BioPharma, Zentalis Pharmaceuticals, Zentiva, Zhittya Genesis Medicine, Zhongze Therapeutics, Zumutor Biologics, Zylo Therapeutics, Zymeworks, ZYUS Life Sciences, ZyVersa Therapeutics

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.